minimum inhibitory concentration mic Search Results


90
Clinical and Laboratory Standards Institute minimum inhibitory concentrations (mics)
Minimum Inhibitory Concentrations (Mics), supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/minimum inhibitory concentrations (mics)/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
minimum inhibitory concentrations (mics) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute mic (minimal inhibitory concentration)
Mic (Minimal Inhibitory Concentration), supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mic (minimal inhibitory concentration)/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
mic (minimal inhibitory concentration) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute minimum inhibitory concentration (mic) by broth microdilution
Minimum Inhibitory Concentration (Mic) By Broth Microdilution, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/minimum inhibitory concentration (mic) by broth microdilution/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
minimum inhibitory concentration (mic) by broth microdilution - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute broth minimum inhibitory concentration (mic) testing
Broth Minimum Inhibitory Concentration (Mic) Testing, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/broth minimum inhibitory concentration (mic) testing/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
broth minimum inhibitory concentration (mic) testing - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute bmd minimum inhibitory concentration (mic) assays
a Structure of CBD. b <t>MIC</t> 90 distribution of CBD against 132 Australian S. aureus isolates. Cumulative percentage of isolates below or equal to a given MIC are indicated. Data are n = 4 biologically independent samples for MIC of each isolate. c MIC 90 distribution of CBD against 100 USA S. aureus isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1 for MIC of each isolate. d Time-kill assay of CBD against MRSA ATCC 43300. Data are mean ± SD for n = 4 biologically independent samples. e <t>Broth</t> <t>microdilution</t> MIC distribution of CBD against 30 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1. f Agar microdilution MIC distribution of CBD against 26 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 3 independent experiments.
Bmd Minimum Inhibitory Concentration (Mic) Assays, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bmd minimum inhibitory concentration (mic) assays/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
bmd minimum inhibitory concentration (mic) assays - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Biofield Corporation minimum inhibitory concentration (mic)
a Structure of CBD. b <t>MIC</t> 90 distribution of CBD against 132 Australian S. aureus isolates. Cumulative percentage of isolates below or equal to a given MIC are indicated. Data are n = 4 biologically independent samples for MIC of each isolate. c MIC 90 distribution of CBD against 100 USA S. aureus isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1 for MIC of each isolate. d Time-kill assay of CBD against MRSA ATCC 43300. Data are mean ± SD for n = 4 biologically independent samples. e <t>Broth</t> <t>microdilution</t> MIC distribution of CBD against 30 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1. f Agar microdilution MIC distribution of CBD against 26 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 3 independent experiments.
Minimum Inhibitory Concentration (Mic), supplied by Biofield Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/minimum inhibitory concentration (mic)/product/Biofield Corporation
Average 90 stars, based on 1 article reviews
minimum inhibitory concentration (mic) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Siemens AG broth microdilution minimum inhibitory concentration (mic) method autoscan
a Structure of CBD. b <t>MIC</t> 90 distribution of CBD against 132 Australian S. aureus isolates. Cumulative percentage of isolates below or equal to a given MIC are indicated. Data are n = 4 biologically independent samples for MIC of each isolate. c MIC 90 distribution of CBD against 100 USA S. aureus isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1 for MIC of each isolate. d Time-kill assay of CBD against MRSA ATCC 43300. Data are mean ± SD for n = 4 biologically independent samples. e <t>Broth</t> <t>microdilution</t> MIC distribution of CBD against 30 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1. f Agar microdilution MIC distribution of CBD against 26 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 3 independent experiments.
Broth Microdilution Minimum Inhibitory Concentration (Mic) Method Autoscan, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/broth microdilution minimum inhibitory concentration (mic) method autoscan/product/Siemens AG
Average 90 stars, based on 1 article reviews
broth microdilution minimum inhibitory concentration (mic) method autoscan - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
ACD Labs Inc mic (minimum inhibitory concentration) values
a Structure of CBD. b <t>MIC</t> 90 distribution of CBD against 132 Australian S. aureus isolates. Cumulative percentage of isolates below or equal to a given MIC are indicated. Data are n = 4 biologically independent samples for MIC of each isolate. c MIC 90 distribution of CBD against 100 USA S. aureus isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1 for MIC of each isolate. d Time-kill assay of CBD against MRSA ATCC 43300. Data are mean ± SD for n = 4 biologically independent samples. e <t>Broth</t> <t>microdilution</t> MIC distribution of CBD against 30 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1. f Agar microdilution MIC distribution of CBD against 26 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 3 independent experiments.
Mic (Minimum Inhibitory Concentration) Values, supplied by ACD Labs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mic (minimum inhibitory concentration) values/product/ACD Labs Inc
Average 90 stars, based on 1 article reviews
mic (minimum inhibitory concentration) values - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute vancomycin minimum inhibitory concentration (mic) susceptibility breakpoint
a Structure of CBD. b <t>MIC</t> 90 distribution of CBD against 132 Australian S. aureus isolates. Cumulative percentage of isolates below or equal to a given MIC are indicated. Data are n = 4 biologically independent samples for MIC of each isolate. c MIC 90 distribution of CBD against 100 USA S. aureus isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1 for MIC of each isolate. d Time-kill assay of CBD against MRSA ATCC 43300. Data are mean ± SD for n = 4 biologically independent samples. e <t>Broth</t> <t>microdilution</t> MIC distribution of CBD against 30 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1. f Agar microdilution MIC distribution of CBD against 26 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 3 independent experiments.
Vancomycin Minimum Inhibitory Concentration (Mic) Susceptibility Breakpoint, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vancomycin minimum inhibitory concentration (mic) susceptibility breakpoint/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
vancomycin minimum inhibitory concentration (mic) susceptibility breakpoint - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute minimum inhibitory concentration (mic) for ahhn1
The cumulative mortality rates of Cyprinus carpio after challenged with <t>AhHN1</t> strain.
Minimum Inhibitory Concentration (Mic) For Ahhn1, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/minimum inhibitory concentration (mic) for ahhn1/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
minimum inhibitory concentration (mic) for ahhn1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
AB Biodisk North American Inc minimum inhibitory concentration (mic) strips
The cumulative mortality rates of Cyprinus carpio after challenged with <t>AhHN1</t> strain.
Minimum Inhibitory Concentration (Mic) Strips, supplied by AB Biodisk North American Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/minimum inhibitory concentration (mic) strips/product/AB Biodisk North American Inc
Average 90 stars, based on 1 article reviews
minimum inhibitory concentration (mic) strips - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute fluconazole minimum inhibitory concentration (mic)
Deletion of CST6 reduces <t>fluconazole</t> hyper-susceptibility of upc2A ∆ mutants. (A) Location of CST6 mutations in evolved strains isolated reported in reference and schematic of Cst6 protein showing position relative to the DNA-binding domain (DBD). (B) A dilution series of the indicated strains were spotted on YPD and YPD with the indicated amount of fluconazole. The plates were incubated for 48 h prior to imaging. The phenotypes are representative of three biological replicates. (C) The indicated strains were plated on YPD medium and incubated in ambient air (normoxia) or in a GAS PAK (hypoxia). (D) Biofilms were generated in RPMI buffered with 0.165 M morpholino-propanesulfonic acid (MOPS) for 72 h before treatment with sham or 1000 µg/mL fluconazole. The wells were incubated for an additional 24 h, and biofilm formation was assayed by metabolic activity as described in Materials and Methods. Bars indicate mean of absorption of the XTT assay, with error bars indicating standard deviation. Asterisks indicate statistically significant differences by one-way analysis of variance followed by Tukey’s correction for multiple comparisons; *<0.05; **<0.01; ***<0.001.
Fluconazole Minimum Inhibitory Concentration (Mic), supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluconazole minimum inhibitory concentration (mic)/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
fluconazole minimum inhibitory concentration (mic) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


a Structure of CBD. b MIC 90 distribution of CBD against 132 Australian S. aureus isolates. Cumulative percentage of isolates below or equal to a given MIC are indicated. Data are n = 4 biologically independent samples for MIC of each isolate. c MIC 90 distribution of CBD against 100 USA S. aureus isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1 for MIC of each isolate. d Time-kill assay of CBD against MRSA ATCC 43300. Data are mean ± SD for n = 4 biologically independent samples. e Broth microdilution MIC distribution of CBD against 30 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1. f Agar microdilution MIC distribution of CBD against 26 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 3 independent experiments.

Journal: Communications Biology

Article Title: The antimicrobial potential of cannabidiol

doi: 10.1038/s42003-020-01530-y

Figure Lengend Snippet: a Structure of CBD. b MIC 90 distribution of CBD against 132 Australian S. aureus isolates. Cumulative percentage of isolates below or equal to a given MIC are indicated. Data are n = 4 biologically independent samples for MIC of each isolate. c MIC 90 distribution of CBD against 100 USA S. aureus isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1 for MIC of each isolate. d Time-kill assay of CBD against MRSA ATCC 43300. Data are mean ± SD for n = 4 biologically independent samples. e Broth microdilution MIC distribution of CBD against 30 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 1. f Agar microdilution MIC distribution of CBD against 26 N. gonorrhoeae isolates. Cumulative number of isolates below or equal to a given MIC are indicated. Data are n = 3 independent experiments.

Article Snippet: Antimicrobial activity of CBD was tested against a number of bacterial strains by broth microdilution (BMD) minimum inhibitory concentration (MIC) assays using procedures described by Clinical and Laboratory Standards Institute (CLSI) – .

Techniques: Time-Kill Assay

The cumulative mortality rates of Cyprinus carpio after challenged with AhHN1 strain.

Journal: The Journal of Veterinary Medical Science

Article Title: Molecular characteristics, pathogenicity and medication regimen of Aeromonas hydrophila isolated from common carp ( Cyprinus carpio L.)

doi: 10.1292/jvms.19-0025

Figure Lengend Snippet: The cumulative mortality rates of Cyprinus carpio after challenged with AhHN1 strain.

Article Snippet: The minimum inhibitory concentration (MIC) for AhHN1 were determined using the broth microdilution protocol following VET04-A2 guideline of Clinical and Laboratory Standards Institute (CLSI) [ ].

Techniques:

Antimicrobial susceptibility patterns of  AhHN1  and Aeromonas hydrophila ATCC 7966

Journal: The Journal of Veterinary Medical Science

Article Title: Molecular characteristics, pathogenicity and medication regimen of Aeromonas hydrophila isolated from common carp ( Cyprinus carpio L.)

doi: 10.1292/jvms.19-0025

Figure Lengend Snippet: Antimicrobial susceptibility patterns of AhHN1 and Aeromonas hydrophila ATCC 7966

Article Snippet: The minimum inhibitory concentration (MIC) for AhHN1 were determined using the broth microdilution protocol following VET04-A2 guideline of Clinical and Laboratory Standards Institute (CLSI) [ ].

Techniques:

Deletion of CST6 reduces fluconazole hyper-susceptibility of upc2A ∆ mutants. (A) Location of CST6 mutations in evolved strains isolated reported in reference and schematic of Cst6 protein showing position relative to the DNA-binding domain (DBD). (B) A dilution series of the indicated strains were spotted on YPD and YPD with the indicated amount of fluconazole. The plates were incubated for 48 h prior to imaging. The phenotypes are representative of three biological replicates. (C) The indicated strains were plated on YPD medium and incubated in ambient air (normoxia) or in a GAS PAK (hypoxia). (D) Biofilms were generated in RPMI buffered with 0.165 M morpholino-propanesulfonic acid (MOPS) for 72 h before treatment with sham or 1000 µg/mL fluconazole. The wells were incubated for an additional 24 h, and biofilm formation was assayed by metabolic activity as described in Materials and Methods. Bars indicate mean of absorption of the XTT assay, with error bars indicating standard deviation. Asterisks indicate statistically significant differences by one-way analysis of variance followed by Tukey’s correction for multiple comparisons; *<0.05; **<0.01; ***<0.001.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Genetic interaction analysis of Candida glabrata transcription factors CST6 and UPC2A in the regulation of respiration and fluconazole susceptibility

doi: 10.1128/aac.01294-24

Figure Lengend Snippet: Deletion of CST6 reduces fluconazole hyper-susceptibility of upc2A ∆ mutants. (A) Location of CST6 mutations in evolved strains isolated reported in reference and schematic of Cst6 protein showing position relative to the DNA-binding domain (DBD). (B) A dilution series of the indicated strains were spotted on YPD and YPD with the indicated amount of fluconazole. The plates were incubated for 48 h prior to imaging. The phenotypes are representative of three biological replicates. (C) The indicated strains were plated on YPD medium and incubated in ambient air (normoxia) or in a GAS PAK (hypoxia). (D) Biofilms were generated in RPMI buffered with 0.165 M morpholino-propanesulfonic acid (MOPS) for 72 h before treatment with sham or 1000 µg/mL fluconazole. The wells were incubated for an additional 24 h, and biofilm formation was assayed by metabolic activity as described in Materials and Methods. Bars indicate mean of absorption of the XTT assay, with error bars indicating standard deviation. Asterisks indicate statistically significant differences by one-way analysis of variance followed by Tukey’s correction for multiple comparisons; *<0.05; **<0.01; ***<0.001.

Article Snippet: The decreased susceptibility of the cst6 ∆ mutant on spot dilution assays is consistent with our previously reported observation that its fluconazole minimum inhibitory concentration (MIC) is fourfold increased relative to WT under Clinical and Laboratory Standards Institute (CLSI) conditions ( ).

Techniques: Isolation, Binding Assay, Incubation, Imaging, Generated, Activity Assay, XTT Assay, Standard Deviation

Deletion of CST6 does not increase ergosterol levels, ERG gene expression or CDR1 efflux pump expression in the presence of fluconazole. (A) The ergosterol content of the indicated strains in the presence of fluconazole (16 µg/mL) was determined as described in Materials and Methods. Bars indicate mean and error bars indicate standard deviation for three biological replicates. * indicates statistically significant difference ( P < 0.05) from WT by one-way analysis of variance (ANOVA) and Tukey’s correction for multiple comparisons. The percentage of (B) lanosterol and (C) 14 methyl ergosta-8,24 (28)-dien-3–6-diol (14-MEDD) relative to total sterols in the indicated strains was determined as described in Materials and Methods in the presence of fluconazole (µg/mL). Full data set provided in . (D) The expression of the indicated genes relative for the upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants relative to WT were determined in the presence of fluconazole (16 µg/mL) by qRT-PCR. The fold change is relative WT, and * indicates statistically significant ( P < 0.05) difference by one-way ANOVA and Tukey’s correction for multiple comparisons. Bars indicate mean of three biological replicates performed in technical triplicate, with error bars indicating standard deviation.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Genetic interaction analysis of Candida glabrata transcription factors CST6 and UPC2A in the regulation of respiration and fluconazole susceptibility

doi: 10.1128/aac.01294-24

Figure Lengend Snippet: Deletion of CST6 does not increase ergosterol levels, ERG gene expression or CDR1 efflux pump expression in the presence of fluconazole. (A) The ergosterol content of the indicated strains in the presence of fluconazole (16 µg/mL) was determined as described in Materials and Methods. Bars indicate mean and error bars indicate standard deviation for three biological replicates. * indicates statistically significant difference ( P < 0.05) from WT by one-way analysis of variance (ANOVA) and Tukey’s correction for multiple comparisons. The percentage of (B) lanosterol and (C) 14 methyl ergosta-8,24 (28)-dien-3–6-diol (14-MEDD) relative to total sterols in the indicated strains was determined as described in Materials and Methods in the presence of fluconazole (µg/mL). Full data set provided in . (D) The expression of the indicated genes relative for the upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants relative to WT were determined in the presence of fluconazole (16 µg/mL) by qRT-PCR. The fold change is relative WT, and * indicates statistically significant ( P < 0.05) difference by one-way ANOVA and Tukey’s correction for multiple comparisons. Bars indicate mean of three biological replicates performed in technical triplicate, with error bars indicating standard deviation.

Article Snippet: The decreased susceptibility of the cst6 ∆ mutant on spot dilution assays is consistent with our previously reported observation that its fluconazole minimum inhibitory concentration (MIC) is fourfold increased relative to WT under Clinical and Laboratory Standards Institute (CLSI) conditions ( ).

Techniques: Gene Expression, Expressing, Standard Deviation, Quantitative RT-PCR

Effect of the cst6 ∆ upc2A ∆ mutant on gene expression relative to single mutants in the presence of fluconazole. (A) Heatmap comparing the expression (RNA-seq) of the indicated ERG genes and the adhesin EPA3 for the upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants relative to WT (BG2). Biological process GO term analysis of genes downregulated in the upc2A ∆ cst6 ∆ (B) and upc2A ∆ (C) mutants in the presence of fluconazole with the number of genes in each GO term group listed on the x-axis. The FDR was determined by Benjamini-Hochberg analysis. (D) Representative mitochondrial and respiration genes downregulated in the upc2A ∆ mutant is shown.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Genetic interaction analysis of Candida glabrata transcription factors CST6 and UPC2A in the regulation of respiration and fluconazole susceptibility

doi: 10.1128/aac.01294-24

Figure Lengend Snippet: Effect of the cst6 ∆ upc2A ∆ mutant on gene expression relative to single mutants in the presence of fluconazole. (A) Heatmap comparing the expression (RNA-seq) of the indicated ERG genes and the adhesin EPA3 for the upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants relative to WT (BG2). Biological process GO term analysis of genes downregulated in the upc2A ∆ cst6 ∆ (B) and upc2A ∆ (C) mutants in the presence of fluconazole with the number of genes in each GO term group listed on the x-axis. The FDR was determined by Benjamini-Hochberg analysis. (D) Representative mitochondrial and respiration genes downregulated in the upc2A ∆ mutant is shown.

Article Snippet: The decreased susceptibility of the cst6 ∆ mutant on spot dilution assays is consistent with our previously reported observation that its fluconazole minimum inhibitory concentration (MIC) is fourfold increased relative to WT under Clinical and Laboratory Standards Institute (CLSI) conditions ( ).

Techniques: Mutagenesis, Gene Expression, Expressing, RNA Sequencing

Forced respiration with glycerol medium increases fluconazole susceptibility of cst6 ∆, upc2A ∆, and upc2A ∆ cst6 ∆ mutants. (A) The upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants were plated on YP + 2% glucose and YP + 2% glycerol medium and incubated at 30°C or 37°C for 48–72 h. (B) The minimum inhibitory concentration (MIC) of fluconazole was determined after incubation for 24 h (glucose) or 48 h (glycerol) at 37°C. (C) The effect of loss of Upc2A function on the expression of ERG genes in the cst6 ∆ mutant by RNA-seq. Full data set is in . All changes were statistically significant (adjusted P < 0.05).

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Genetic interaction analysis of Candida glabrata transcription factors CST6 and UPC2A in the regulation of respiration and fluconazole susceptibility

doi: 10.1128/aac.01294-24

Figure Lengend Snippet: Forced respiration with glycerol medium increases fluconazole susceptibility of cst6 ∆, upc2A ∆, and upc2A ∆ cst6 ∆ mutants. (A) The upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants were plated on YP + 2% glucose and YP + 2% glycerol medium and incubated at 30°C or 37°C for 48–72 h. (B) The minimum inhibitory concentration (MIC) of fluconazole was determined after incubation for 24 h (glucose) or 48 h (glycerol) at 37°C. (C) The effect of loss of Upc2A function on the expression of ERG genes in the cst6 ∆ mutant by RNA-seq. Full data set is in . All changes were statistically significant (adjusted P < 0.05).

Article Snippet: The decreased susceptibility of the cst6 ∆ mutant on spot dilution assays is consistent with our previously reported observation that its fluconazole minimum inhibitory concentration (MIC) is fourfold increased relative to WT under Clinical and Laboratory Standards Institute (CLSI) conditions ( ).

Techniques: Incubation, Concentration Assay, Expressing, Mutagenesis, RNA Sequencing